RecruitingNCT06375941
Prospective Observational Study of Localized Angiosarcoma of Any Site: ProStars
Sponsor
Italian Sarcoma Group
Enrollment
250 participants
Start Date
Mar 29, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
This study will be a multi-institutional, prospective, observational study of patients with localized primary AS of any site within ISG and RTR centers. Patients will be treated according to clinical practice of the center and according to ISG clinical recommendations on localized AS.
Eligibility
Inclusion Criteria4
- pathological diagnosis of AS;
- any site of origin;
- any age;
- primary, localized, resectable disease.
Interventions
OTHERObservational
Observational
Locations(19)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06375941
Related Trials
Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for Angiosarcoma
NCT068989701 location
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
NCT0104237942 locations
Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients
NCT074329321 location
Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas
NCT0405522016 locations
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
NCT064400056 locations